Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Prignano

Showing results (101-110 of 194) with videos related to

Pageof 20
Sort By:
Experimental Cell Research|May 22, 2016
Interleukin 22 early affects keratinocyte differentiation, but not proliferation, in a three-dimensional model of normal human skinElena Donetti, Laura Cornaghi, Francesca Arnaboldi, et al.
Italian Journal of Dermatology and Venereology|December 11, 2025
Forty-eight-week safety of bimekizumab in psoriasis: focus on infectious comorbiditiesEmanuele Trovato, Alberta Bettacchi, Tommaso Bianchelli, et al.
Dermatology (Basel, Switzerland)|March 17, 2024
Epidemiology, Characteristics of Disease, and Unmet Needs of Patients with Generalized Pustular Psoriasis: A Large Italian Delphi ConsensusFrancesca Prignano, Laura Atzori, Francesco Bellinato, et al.
The British Journal of Dermatology|March 16, 2022
Identification of clinical features affecting diagnostic delay in paediatric hidradenitis suppurativa: results from a multicentre observational studyAntonella Di Cesare, Georgios Nikolakis, Theodora Kanni, et al.
Expert Opinion on Biological Therapy|May 2, 2025
What is '<i>chronic</i>' pustular psoriasis? Identifying candidates for long-term subcutaneous spesolimab treatmentAngelo Valerio Marzano, Carlo Alberto Maronese, Anna Balato, et al.
Italian Journal of Dermatology and Venereology|January 18, 2023
Pustular psoriasis with a focus on generalized pustular psoriasis: classification and diagnostic criteria. An Italian expert consensusAntonio Costanzo, Federico Bardazzi, Clara DE Simone, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 17, 2018
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated DisordersFrancesca Nencini, Alessandra Vultaggio, Sara Pratesi, et al.
Autoimmunity Reviews|January 25, 2015
Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practiceFabrizio Cantini, Carlotta Nannini, Laura Niccoli, et al.
Expert Review of Clinical Immunology|October 26, 2021
Risk of infections in psoriasis: assessment and challenges in daily managementClara De Simone, Maria Concetta Fargnoli, Paolo Amerio, et al.
Journal of Dermatological Science|February 16, 2015
Erythrodermic psoriasis treated with ustekinumab: an Italian multicenter retrospective analysisLeonardo Pescitelli, Valentina Dini, Paolo Gisondi, et al.
Pageof 20

Showing results (101-110 of 194) with videos related to

Sort By:
Pageof 20
Experimental Cell Research|May 22, 2016
Interleukin 22 early affects keratinocyte differentiation, but not proliferation, in a three-dimensional model of normal human skinElena Donetti, Laura Cornaghi, Francesca Arnaboldi, et al.
Italian Journal of Dermatology and Venereology|December 11, 2025
Forty-eight-week safety of bimekizumab in psoriasis: focus on infectious comorbiditiesEmanuele Trovato, Alberta Bettacchi, Tommaso Bianchelli, et al.
Dermatology (Basel, Switzerland)|March 17, 2024
Epidemiology, Characteristics of Disease, and Unmet Needs of Patients with Generalized Pustular Psoriasis: A Large Italian Delphi ConsensusFrancesca Prignano, Laura Atzori, Francesco Bellinato, et al.
The British Journal of Dermatology|March 16, 2022
Identification of clinical features affecting diagnostic delay in paediatric hidradenitis suppurativa: results from a multicentre observational studyAntonella Di Cesare, Georgios Nikolakis, Theodora Kanni, et al.
Expert Opinion on Biological Therapy|May 2, 2025
What is '<i>chronic</i>' pustular psoriasis? Identifying candidates for long-term subcutaneous spesolimab treatmentAngelo Valerio Marzano, Carlo Alberto Maronese, Anna Balato, et al.
Italian Journal of Dermatology and Venereology|January 18, 2023
Pustular psoriasis with a focus on generalized pustular psoriasis: classification and diagnostic criteria. An Italian expert consensusAntonio Costanzo, Federico Bardazzi, Clara DE Simone, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 17, 2018
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated DisordersFrancesca Nencini, Alessandra Vultaggio, Sara Pratesi, et al.
Autoimmunity Reviews|January 25, 2015
Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practiceFabrizio Cantini, Carlotta Nannini, Laura Niccoli, et al.
Expert Review of Clinical Immunology|October 26, 2021
Risk of infections in psoriasis: assessment and challenges in daily managementClara De Simone, Maria Concetta Fargnoli, Paolo Amerio, et al.
Journal of Dermatological Science|February 16, 2015
Erythrodermic psoriasis treated with ustekinumab: an Italian multicenter retrospective analysisLeonardo Pescitelli, Valentina Dini, Paolo Gisondi, et al.
Pageof 20